Repurposing antimalarials and other drugs for COVID-19.
作者信息
Schlagenhauf Patricia, Grobusch Martin P, Maier Julian D, Gautret Philippe
机构信息
University of Zurich Centre for Travel Medicine, WHO Collaborating for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Hirschengraben 84, 8001, Zurich, Switzerland.
Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
出版信息
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
Abstract
摘要
相似文献
1
Repurposing antimalarials and other drugs for COVID-19.
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
2
Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Int J Antimicrob Agents. 2020 Jun;55(6):105969. doi: 10.1016/j.ijantimicag.2020.105969. Epub 2020 Apr 9.
3
Race to find COVID-19 treatments accelerates.
Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.
4
Treatments for COVID-19: where are we now?
Br J Community Nurs. 2020 Aug 2;25(8):412-413. doi: 10.12968/bjcn.2020.25.8.412.
5
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
6
Uncertainty about the Efficacy of Remdesivir on COVID-19.
J Korean Med Sci. 2020 Jun 15;35(23):e221. doi: 10.3346/jkms.2020.35.e221.
7
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
8
Audio Interview: New Data on Remdesivir in Covid-19.
N Engl J Med. 2020 May 28;382(22):e94. doi: 10.1056/NEJMe2019975.
9
Communicating Science in the Time of a Pandemic.
JAMA. 2020 Aug 4;324(5):443-444. doi: 10.1001/jama.2020.12535.
10
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
JAMA Intern Med. 2020 Oct 1;180(10):1273-1274. doi: 10.1001/jamainternmed.2020.2759.
引用本文的文献
1
Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine.
Clin Pharmacol. 2025 Jan 16;17:1-11. doi: 10.2147/CPAA.S493750. eCollection 2025.
2
In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies.
Adv Appl Bioinform Chem. 2022 Aug 15;15:59-77. doi: 10.2147/AABC.S366111. eCollection 2022.
3
Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies.
Adv Pharm Bull. 2022 Jan;12(1):34-44. doi: 10.34172/apb.2022.005. Epub 2021 Jan 30.
4
Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M) as Potential COVID-19 Therapies.
Front Mol Biosci. 2022 Mar 14;9:781039. doi: 10.3389/fmolb.2022.781039. eCollection 2022.
5
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study.
Arab J Chem. 2021 Sep;14(9):103315. doi: 10.1016/j.arabjc.2021.103315. Epub 2021 Jul 14.
6
Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection.
J Epidemiol Glob Health. 2021 Sep;11(3):283-288. doi: 10.2991/jegh.k.210518.001. Epub 2021 May 23.
7
Drug repurposing against coronavirus disease 2019 (COVID-19): A review.
J Pharm Anal. 2021 Dec;11(6):683-690. doi: 10.1016/j.jpha.2021.09.001. Epub 2021 Sep 4.
8
Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection.
Indian J Med Res. 2021 May;153(5&6):564-565. doi: 10.4103/ijmr.ijmr_1092_21.
9
Recent updates on the possible reasons for the low incidence and morbidity of COVID-19 cases in Africa.
Bull Natl Res Cent. 2021;45(1):133. doi: 10.1186/s42269-021-00589-9. Epub 2021 Jul 23.
10
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
Covid-19 and community mitigation strategies in a pandemic.
BMJ. 2020 Mar 17;368:m1066. doi: 10.1136/bmj.m1066.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
5
Remdesivir as a possible therapeutic option for the COVID-19.
Travel Med Infect Dis. 2020 Mar-Apr;34:101615. doi: 10.1016/j.tmaid.2020.101615. Epub 2020 Mar 5.
6
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
8
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
9
A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Travel Med Infect Dis. 2019 Jul-Aug;30:9-18. doi: 10.1016/j.tmaid.2019.06.012. Epub 2019 Jun 25.
10
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study.
BMJ. 2003 Nov 8;327(7423):1078. doi: 10.1136/bmj.327.7423.1078.
Zotero 插件